Mu-Sheng Zeng相关文献与解析，生知库 | 链接生命科学的每一步

Yan Li # ，Hua Zhang # ，Cong Sun # ，Xiao-Dong Dong # ，Chu Xie ，Yuan-Tao Liu ，Ruo-Bin Lin ，Xiang-Wei Kong ，Zhu-Long Hu ，Xiao-Yan Ma ，Dan-Ling Dai ，Qian-Ying Zhu ，Yu-Chun Li ，Ying Li ，Shang-Xin Liu ，Li Yuan ，Peng-Hui Zhou ，Song Gao ，Ya-Ping Tang ，Jin-Ying Yang ，Ping Han ，Andrew T McGuire ，Bo Zhao ，Jin-Xin Bei ，Erle Robertson ，Yi-Xin Zeng ，Qian Zhong ，Mu-Sheng Zeng

上皮细胞

炎症/感染

免疫/内分泌

Retraction Note: Vasculogenic mimicry formation in EBV-associated epithelial malignancies

撤稿声明：EBV相关上皮恶性肿瘤中的血管生成拟态形成

期刊:Nature Communications

影响因子:15.7

doi:10.1038/s41467-025-65413-8

Xiang, Tong; Lin, Yu-Xin; Ma, Wenlong; Zhang, Hao-Jiong; Chen, Ke-Ming; He, Gui-Ping; Zhang, Xiao; Xu, Miao; Feng, Qi-Sheng; Chen, Ming-Yuan; Zeng, Mu-Sheng; Zeng, Yi-Xin; Feng, Lin

The PLEKHA1-TACC2 fusion gene drives tumorigenesis via vascular mimicry formation in esophageal squamous-cell carcinoma

PLEKHA1-TACC2融合基因通过血管拟态形成驱动食管鳞状细胞癌的肿瘤发生

期刊:Cell Death and Differentiation

影响因子:13.7

doi:10.1038/s41418-025-01536-1

Ting Yang #,Zhi-Rui Lin #,Tian-Liang Xia #,Shang-Xin Liu #,Bo-Yu Yuan,Yi-Ling Luo,Wen-Ting Du,Chao-Bo Lei,Yong-Zhan Nie,Mu-Sheng Zeng,Qian Zhong

Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma

干扰素反应性高内皮静脉驱动肿瘤三级淋巴结构形成，并预测鼻咽癌的免疫治疗反应

期刊:Cell Reports Medicine

影响因子:11.7

doi:10.1016/j.xcrm.2025.102200

Shang-Xin Liu ，Tao-Wei Wu ，Dong-Hua Luo ，Le-Le Zhang ，Lu Zhou ，Yi-Ling Luo ，Wen-Ting Du ，Ting-Ting Huang ，Sizun Jiang ，Zhe Zhang ，Ping Han ，Mu-Sheng Zeng ，Qian Zhong

A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection

针对关键进入糖蛋白的鸡尾酒纳米疫苗可引发针对 EBV 感染的高水平中和抗体

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-024-49546-w

Ling Zhong #, Wanlin Zhang #, Hong Liu #, Xinyu Zhang #, Zeyu Yang, Zhenfu Wen, Ling Chen, Haolin Chen, Yanran Luo, Yanhong Chen, Qisheng Feng, Mu-Sheng Zeng, Qinjian Zhao, Lixin Liu, Claude Krummenacher, Yi-Xin Zeng, Yongming Chen, Miao Xu, Xiao Zhang

其它

发表日期：2024

文献求助收藏

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

一种用于治疗KRAS突变型癌症的泛KRAS降解剂

期刊:Cell Discovery

影响因子:13

doi:10.1038/s41421-024-00699-4

Jie Yang # ，Qiao-Li Wang # ，Guan-Nan Wang ，Jia-Cong Ye ，Zi-Qian Li ，Jing-Yun Wang ，Zhao-Hui Liang ，Shu-Xin Li ，Cong Sun ，Wen-Ting Liao ，Yi-Jun Gao ，Jing Wang ，Yong Mao ，Chunjing Yu ，Guo-Kai Feng ，Mu-Sheng Zeng

Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection

针对 Epstein-Barr 病毒 gp42 的强效人类单克隆抗体揭示了病毒感染的脆弱部位

期刊:Cell Reports Medicine

影响因子:11.7

doi:10.1016/j.xcrm.2024.101573

Ge-Xin Zhao, Xin-Yan Fang, Guo-Long Bu, Shuai-Jia-Bin Chen, Cong Sun, Ting Li, Chu Xie, Yu Wang, Shu-Xin Li, Ning Meng, Guo-Kai Feng, Qian Zhong, Xiang-Wei Kong, Zheng Liu, Mu-Sheng Zeng

TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice

基于天坛痘苗病毒的EBV疫苗，靶向潜伏抗原和裂解抗原，可在人源化小鼠中诱导针对致命性EBV攻击的强效免疫力。

期刊:Emerging Microbes & Infections

影响因子:8.4

doi:10.1080/22221751.2024.2412640

Xinyu Zhang ，Yanhong Chen ，Shuhui Wang ，Ling Zhong ，Zheng Xiang ，Xiao Zhang ，Shanshan Zhang ，Xiang Zhou ，Wanlin Zhang ，Yan Zhou ，Qiuting Zhang ，Jingtong Liang ，Yanran Luo ，Yufei Wang ，Ling Chen ，Xiaoping Ye ，Qisheng Feng ，Mu-Sheng Zeng ，Ying Liu ，Yi-Xin Zeng ，Yiming Shao ，Miao Xu

EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation

EBV 失活裂解周期通过募集单核细胞并调节其定向分化来促进鼻咽癌的进展。

期刊:PLoS Pathogens

影响因子:5.5

doi:10.1371/journal.ppat.1011934

Xiaoting Xu ，Nannan Zhu ，Junming Zheng ，Yingying Peng ，Mu-Sheng Zeng ，Kai Deng ，Chaohui Duan ，Yan Yuan

A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth

DNA肿瘤病毒全局重新编程宿主三维基因组结构以实现永生生长

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-023-37347-6

Chong Wang #, Xiang Liu #, Jun Liang #, Yohei Narita #, Weiyue Ding #, Difei Li, Luyao Zhang, Hongbo Wang, Merrin Man Long Leong, Isabella Hou, Catherine Gerdt, Chang Jiang, Qian Zhong, Zhonghui Tang, Carmy Forney, Leah Kottyan, Matthew T Weirauch, Benjamin E Gewurz, Mu-Sheng Zeng, Sizun Jiang, Ming

R9AP is a common receptor for EBV infection in epithelial cells and B cells

R9AP是上皮细胞和B细胞中EB病毒感染的常见受体。

Retraction Note: Vasculogenic mimicry formation in EBV-associated epithelial malignancies

撤稿声明：EBV相关上皮恶性肿瘤中的血管生成拟态形成

The PLEKHA1-TACC2 fusion gene drives tumorigenesis via vascular mimicry formation in esophageal squamous-cell carcinoma

PLEKHA1-TACC2融合基因通过血管拟态形成驱动食管鳞状细胞癌的肿瘤发生

Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma

干扰素反应性高内皮静脉驱动肿瘤三级淋巴结构形成，并预测鼻咽癌的免疫治疗反应

A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection

针对关键进入糖蛋白的鸡尾酒纳米疫苗可引发针对 EBV 感染的高水平中和抗体

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

一种用于治疗KRAS突变型癌症的泛KRAS降解剂

Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection

针对 Epstein-Barr 病毒 gp42 的强效人类单克隆抗体揭示了病毒感染的脆弱部位

TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice

基于天坛痘苗病毒的EBV疫苗，靶向潜伏抗原和裂解抗原，可在人源化小鼠中诱导针对致命性EBV攻击的强效免疫力。

EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation

EBV 失活裂解周期通过募集单核细胞并调节其定向分化来促进鼻咽癌的进展。

A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth

DNA肿瘤病毒全局重新编程宿主三维基因组结构以实现永生生长